|
Name |
1-Ethyl-1-heptyloxy-1-silacyclohexane
|
Molecular Formula | C14H30OSi | |
IUPAC Name* |
1-ethyl-1-heptoxysilinane
|
|
SMILES |
CCCCCCCO[Si]1(CCCCC1)CC
|
|
InChI |
InChI=1S/C14H30OSi/c1-3-5-6-7-9-12-15-16(4-2)13-10-8-11-14-16/h3-14H2,1-2H3
|
|
InChIKey |
PKYSCKBPESWZCV-UHFFFAOYSA-N
|
|
Synonyms |
1-Ethyl-1-heptyloxy-1-silacyclohexane; 1-Ethyl-1-(heptyloxy)silinane #
|
|
CAS | NA | |
PubChem CID | 611532 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 242.47 | ALogp: | 5.1 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 9.2 | Aromatic Rings: | 1 |
Heavy Atoms: | 16 | QED Weighted: | 0.407 |
Caco-2 Permeability: | -4.672 | MDCK Permeability: | 0.00002380 |
Pgp-inhibitor: | 0.037 | Pgp-substrate: | 0.567 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.159 |
30% Bioavailability (F30%): | 0.013 |
Blood-Brain-Barrier Penetration (BBB): | 0.064 | Plasma Protein Binding (PPB): | 99.30% |
Volume Distribution (VD): | 2.106 | Fu: | 1.26% |
CYP1A2-inhibitor: | 0.716 | CYP1A2-substrate: | 0.55 |
CYP2C19-inhibitor: | 0.216 | CYP2C19-substrate: | 0.416 |
CYP2C9-inhibitor: | 0.269 | CYP2C9-substrate: | 0.488 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.043 |
CYP3A4-inhibitor: | 0.036 | CYP3A4-substrate: | 0.02 |
Clearance (CL): | 5.365 | Half-life (T1/2): | 0.134 |
hERG Blockers: | 0.028 | Human Hepatotoxicity (H-HT): | 0.029 |
Drug-inuced Liver Injury (DILI): | 0.021 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.001 | Maximum Recommended Daily Dose: | 0.926 |
Skin Sensitization: | 0.923 | Carcinogencity: | 0.364 |
Eye Corrosion: | 0.985 | Eye Irritation: | 0.975 |
Respiratory Toxicity: | 0.876 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001391 | 0.492 | D05ATI | 0.292 | ||||
ENC001167 | 0.438 | D0AY9Q | 0.275 | ||||
ENC000855 | 0.396 | D0Z5SM | 0.266 | ||||
ENC000261 | 0.392 | D01QLH | 0.259 | ||||
ENC000897 | 0.392 | D0IX1A | 0.250 | ||||
ENC000854 | 0.383 | D04QLR | 0.244 | ||||
ENC000279 | 0.383 | D0XN8C | 0.235 | ||||
ENC000268 | 0.375 | D03ZJE | 0.235 | ||||
ENC000493 | 0.370 | D00FGR | 0.222 | ||||
ENC000797 | 0.357 | D01UUD | 0.221 |